Edesa Biotech
(NASDAQ) EDSA
Edesa Biotech Financials at a Glance
Market Cap
$49.42M
Revenue (TTM)
$0.00
Net Income (TTM)
$7.82M
EPS (TTM)
$-1.15
P/E Ratio
-5.16
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$5.55
Volume
204,921.538
Open
$5.99
Price
$5.55
Volume
204,921.538
Open
$5.99
Previous Close
$5.52
Daily Range
$5.51 - $6.18
52-Week Range
$0.72 - $9.37
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$5.55
Volume
204,921.538
Open
$5.99
Previous Close
$5.52
Daily Range
$5.51 - $6.18
52-Week Range
$0.72 - $9.37
EDSA News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Edesa Biotech
Industry
Biotechnology
Sector
Health CareEmployees
17
CEO
Pardeep Nijhawan, MD
Website
www.edesabiotech.comHeadquarters
Markham, ON L3R 5H6, CA
EDSA Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-96%
Return on Capital
-60%
Return on Assets
-53%
Earnings Yield
-19.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$49.42M
Shares Outstanding
8.35M
Volume
204.92K
Short Interest
0.00%
Avg. Volume
4.38M
Financials (TTM)
Gross Profit
$119.27K
Operating Income
$7.91M
EBITDA
$7.07M
Operating Cash Flow
$7.32M
Capital Expenditure
$0.00
Free Cash Flow
$7.32M
Cash & ST Invst.
$10.79M
Total Debt
$0.00
Edesa Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$25.46K
+40.9%
Gross Margin
0.00%
N/A
Market Cap
$49.42M
N/A
Market Cap/Employee
$3.09M
N/A
Employees
16
N/A
Net Income
$2.25M
-39.0%
EBITDA
$2.32M
-47.1%
Quarterly Fundamentals
Net Cash
$12.05M
+670.8%
Accounts Receivable
$431.32K
+23.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-53.13%
N/A
Return on Invested Capital
-59.87%
N/A
Free Cash Flow
$2.09M
-37.6%
Operating Cash Flow
$2.09M
-37.6%